Posts by: Patricia Inacio PhD

Patricia Inacio PhD

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.

November 19, 2015November 19, 2015

Potential Approach to Decrease Immune Responses in IBD Suggested by BIDMC Researchers

News

In a new study entitled “NADH oxidase-dependent CD39 expression by CD8+ T cells modulates interferon gamma responses via generation of adenosine,” a team of researchers shed light on the role ... Read more

November 9, 2015November 9, 2015

For IBD Patients, Dietary Fiber Has Multiple Benefits

News

In a recent review study entitled “The role of dietary fibre in inflammatory bowel disease,” researchers reviewed and summarized the current knowledge of the potential anti-inflammatory effects of dietary fiber in ... Read more

October 23, 2015October 23, 2015

IBD Drug Delivery Directly to GI Tract May Be Possible with Ultrasound

News

In a new study entitled “Ultrasound-mediated gastrointestinal drug delivery,” a team of scientists report a new method using ultrasounds to deliver, fast and efficiently, drugs to the gastrointestinal tract. This ... Read more

October 15, 2015October 15, 2015

Placental Inflammation Not Related to Poor Birth Outcomes in Women with IBD

News

In a recent study entitled “Placental inflammation is not increased in inflammatory bowel disease”, researchers investigated whether women with inflammatory bowel disease (IBD) exhibit higher rates of placental inflammation, and ... Read more

October 13, 2015October 27, 2015

Patients with Complex IBD at Increased Risk of Renal Cell Carcinoma, but with Better Survival Outcomes

News

In a new study entitled “Better survival of renal cell carcinoma in patients with inflammatory bowel disease”, researchers investigated whether the commonly used immunosuppressive and anti-TNFα therapies in inflammatory bowel disease ... Read more

September 30, 2015September 30, 2015

NIH Research Grant Awarded to Foster the Development of Oral IL-23 Receptor Antagonists for IBD

News

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute that is part of the National Institute of Health (NIH), recently granted a Phase 1 Small Business ... Read more

September 28, 2015September 28, 2015

Endoscopic Balloon Dilation Long-Term Benefits for Crohn’s Disease Strictures Needs Further Evaluation

News

In a recent review study entitled “Systematic review with meta-analysis: endoscopic balloon dilatation for Crohn’s disease strictures”, researchers performed a systematic analysis to determine the overall efficacy of endoscopic balloon dilation ... Read more

September 17, 2015September 17, 2015

Type I IFNs Incapable of Inducing Remission in Ulcerative Colitis

News

In a recent review study entitled “Type I interferons for induction of remission in ulcerative colitis”, the authors revised clinical studies and concluded that type I interferon therapy, successfully used in ... Read more

September 3, 2015September 3, 2015

New Mechanism Underlying Drug Resistance in Crohn’s Disease Identified

Crohn's Disease, News

In a new study entitled “Chronic inflammation up-regulates P-gp in peripheral mononuclear blood cells via the STAT3/Nf-κb pathway in 2,4,6-trinitrobenzene sulfuric acid-induced colitis mice,” researchers identified a mechanism underlying drug resistance ... Read more

August 27, 2015August 27, 2015

Genetic Risk Factors for IBD Identified in African-American Population

IBD News, News

In a new study entitled “Characterization of Genetic Loci That Affect Susceptibility to Inflammatory Bowel Diseases in African Americans,” researchers investigated the genetic causes for inflammatory bowel disease (IBD) in ... Read more